Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fybrosis-related isolates

Coenye, T., Mahenthiralingam, Eshwar ORCID: https://orcid.org/0000-0001-9014-3790, Henry, D., LiPuma, J. J., Laevens, S., Gillis, M., Speert, D. P. and Vandamme, P. 2001. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fybrosis-related isolates. International Journal of Systematic and Evolutionary Microbiology 51 (4) , pp. 1481-1490. 10.1099/00207713-51-4-1481

Full text not available from this repository.

Abstract

A polyphasic taxonomic study, including amplified fragment length polymorphism (AFLP) fingerprinting, DNA-DNA hybridizations, DNA base-ratio determinations, phylogenetic analysis, whole-cell fatty acid analyses and an extensive biochemical characterization, was performed on 19 Burkholderia cepacia-like isolates from the environment and cystic fibrosis (CF) patients. Several of the environmental isolates have attracted considerable interest due to their biocontrol properties. The polyphasic taxonomic data showed that the strains represent a new member of the B. cepacia complex, for which the name Burkholderia ambifaria sp. nov. is proposed. The type strain is strain LMG 19182T. B. ambifaria can be differentiated from the other members of the B. cepacia complex by means of AFLP fingerprinting, whole-cell fatty acid analysis, biochemical tests (including ornithine and lysine decarboxylase activity, acidification of sucrose and beta-haemolysis) and a newly developed recA gene-based PCR assay. 16S rDNA-based RFLP analysis and PCR tests allowed differentiation of B. ambifaria from Burkholderia multivorans, Burkholderia vietnamiensis and B. cepacia genomovar VI, but not from B. cepacia genomovars I and III and Burkholderia stabilis. The finding that this new taxon includes both strains isolated from CF patients and potentially useful biocontrol strains supports the general consensus that the large-scale use of biocontrol strains belonging to the B. cepacia complex would be ill-advised until more is known about their potential pathogenic mechanisms.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Subjects:	Q Science > Q Science (General)
Additional Information:	DOI does not work.
Publisher:	Society for General Microbiology
ISSN:	1466-5026
Last Modified:	27 Oct 2022 09:01
URI:	https://orca.cardiff.ac.uk/id/eprint/64117

Citation Data

Cited 214 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item